Tom Lazenby
Founder & CEO, Mayet
Key Points
- Identifying problems in clinical trials is crucial for innovation
- Siloed work in clinical trials creates significant challenges
- Finding the right partners is essential for startup success
- Validating ideas through feedback is a key step in entrepreneurship
- Transitioning from quality roles to leadership requires adaptability
- Using software reduces compliance risks in vendor management
- Aligning technology with SOPs can enhance efficiency
- Future plans for Mayet include expanding functionalities and partnerships
In this special episode, Tom is interviewed by Kalyan Obalampalli, where they discuss the journey of Mayet, a vendor management software for clinical trials. Tom shares insights on the importance of integrity in business, the challenges of vendor management, and the significance of finding the right partners. They also delve into the transition from quality roles to leadership in a startup, the functionality of Mayet, and the future plans for the company. Personal anecdotes about hobbies and interests add a relatable touch to the conversation.
Chapters
About the Guest
Tom Lazenby
Founder & CEO, Mayet
Tom Lazenby is the Founder and CEO of Mayet, bringing a decade of clinical QA leadership to the vendor oversight space. He built Mayet to help pharma and biotech sponsors operationalise their vendor management with software purpose-built for ICH E6(R3) compliance.
In this special episode, the tables are turned as Tom is interviewed by Kalyan Obalampalli, Founder of Clin.AI.
Want to discuss vendor oversight?
Book a consultation with Tom Lazenby to explore how Mayet can support your clinical QA needs.